{
    "body": "What is the role of NETs in systemic lupus erythematosus?", 
    "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/24570026", 
        "http://www.ncbi.nlm.nih.gov/pubmed/23945056", 
        "http://www.ncbi.nlm.nih.gov/pubmed/23248629", 
        "http://www.ncbi.nlm.nih.gov/pubmed/21613614", 
        "http://www.ncbi.nlm.nih.gov/pubmed/24205237", 
        "http://www.ncbi.nlm.nih.gov/pubmed/25500436", 
        "http://www.ncbi.nlm.nih.gov/pubmed/22345666", 
        "http://www.ncbi.nlm.nih.gov/pubmed/22617827", 
        "http://www.ncbi.nlm.nih.gov/pubmed/21389264", 
        "http://www.ncbi.nlm.nih.gov/pubmed/24497360", 
        "http://www.ncbi.nlm.nih.gov/pubmed/24838349", 
        "http://www.ncbi.nlm.nih.gov/pubmed/23267025", 
        "http://www.ncbi.nlm.nih.gov/pubmed/24758196", 
        "http://www.ncbi.nlm.nih.gov/pubmed/24295292", 
        "http://www.ncbi.nlm.nih.gov/pubmed/23224024", 
        "http://www.ncbi.nlm.nih.gov/pubmed/20439745"
    ], 
    "triples": [
        {
            "p": "http://www.w3.org/2004/02/skos/core#notation", 
            "s": "http://linkedlifedata.com/resource/umls/label/A0081309", 
            "o": "D008180"
        }, 
        {
            "p": "http://www.w3.org/2004/02/skos/core#notation", 
            "s": "http://linkedlifedata.com/resource/umls/label/A12999583", 
            "o": "D008180"
        }
    ], 
    "ideal_answer": [
        "Neutrophil extracellular traps (NETs) are released via a novel form of cell death called NETosis. NETs, consisting of a chromatin meshwork decorated with antimicrobial peptides, play an important role in the innate response to microbial infections. Clearance of NETs is impaired in a subset of patients with systemic lupus erythematosus, and NETosis is increased in these patients low-density granulocytes, a phenotype that correlates with disease activity. NETs are composed of secreted chromatin that may act as a source of autoantigens typical for SLE. NETs can directly damage tissues - including the endothelium - with implications for lupus nephritis and accelerated atherosclerosis."
    ], 
    "concepts": [
        "http://www.disease-ontology.org/api/metadata/DOID:9074", 
        "http://www.nlm.nih.gov/cgi/mesh/2016/MB_cgi?field=uid&exact=Find+Exact+Term&term=D008180"
    ], 
    "type": "summary", 
    "id": "56ccccf55795f9a73e000037", 
    "snippets": [
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 498, 
            "text": "Neutrophil extracellular traps (NETs) represent an important defense mechanism against microorganisms. Clearance of NETs is impaired in a subset of patients with systemic lupus erythematosus, and NETosis is increased in neutrophils and, particularly, in low-density granulocytes derived from lupus patients. NETs are toxic to the endothelium, expose immunostimulatory molecules, activate plasmacytoid dendritic cells, and may participate in organ damage through incompletely characterized pathways.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/23267025", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 257, 
            "offsetInEndSection": 755, 
            "text": "Neutrophil extracellular traps (NETs) are released via a novel form of cell death called NETosis. NETs, consisting of a chromatin meshwork decorated with antimicrobial peptides, play an important role in the innate response to microbial infections. Some lupus patients do not clear NETs normally, a phenotype that correlates with disease activity. Further, lupus neutrophils - and, in particular, an aberrant subset called low-density granulocytes - have an increased propensity to undergo NETosis.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/22617827", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 1032, 
            "offsetInEndSection": 1172, 
            "text": " NETs can also directly damage tissues - including the endothelium - with implications for lupus nephritis and accelerated atherosclerosis. ", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/22617827", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 120, 
            "offsetInEndSection": 264, 
            "text": "Antimicrobial neutrophil extracellular traps (NETs) are composed of secreted chromatin that may act as a source of autoantigens typical for SLE.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/22345666", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 259, 
            "text": "Neutrophil extracellular traps (NETs) have been implicated in the pathogenesis of systemic Lupus erythematosus (SLE), since netting neutrophils release potentially immunogenic autoantigens including histones, LL37, human neutrophil peptide (HNP), and self-DNA", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/24205237", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 202, 
            "text": "Elevated Plasma cfDNA May be Associated with Active Lupus Nephritis and Partially Attributed to Abnormal Regulation of Neutrophil Extracellular Traps (NETs) in Patients with Systemic Lupus Erythematosus", 
            "beginSection": "title", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/25500436", 
            "endSection": "title"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 135, 
            "text": "The ability to degrade neutrophil extracellular traps (NETs) is reduced in a subset of patients with systemic lupus erythematosus (SLE)", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/23945056", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 193, 
            "text": "A decreased ability to degrade neutrophil extracellular traps (NETs) is seen in a subgroup of patients with systemic lupus erythematosus (SLE) and correlates with the presence of autoantibodies", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/24295292", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 411, 
            "offsetInEndSection": 571, 
            "text": "Recent studies have demonstrated that dysregulation of NETs could be involved in the pathogenesis of autoimmune diseases, including systemic lupus erythematosus", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/23224024", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 415, 
            "offsetInEndSection": 622, 
            "text": "Both exuberant NETosis and impaired clearance of NETs have been implicated in the organ damage of autoimmune diseases, such as systemic lupus erythematosus (SLE), small vessel vasculitis (SVV), and psoriasis", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/23248629", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 138, 
            "text": "Netting neutrophils induce endothelial damage, infiltrate tissues, and expose immunostimulatory molecules in systemic lupus erythematosus.", 
            "beginSection": "title", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/21613614", 
            "endSection": "title"
        }, 
        {
            "offsetInBeginSection": 297, 
            "offsetInEndSection": 781, 
            "text": "Neutrophil extracellular trap (NET) formation is increased in SLE and has been proposed to contribute to endothelial damage, but the mechanism remains unclear.OBJECTIVE: To determine the mechanism by which enhanced NET formation by low-density granulocytes (LDGs) in SLE contributes to endothelial damage and disrupts the endothelium.RESULTS: The putative role of NET-externalised matrix metalloproteinases (MMPs) in altering the functional integrity of the endothelium was examined. ", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/24570026", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 265, 
            "offsetInEndSection": 398, 
            "text": "In this study, we investigated how complement interacts with NETs and how NET degradation is affected by complement in SLE patients. ", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/22345666", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 835, 
            "offsetInEndSection": 1131, 
            "text": "NETs are a potent stimulus for IFN\u03b1 release by plasmacytoid dendritic cells, and, as such, may play an important role in propagation of the lupus phenotype. NETs can also directly damage tissues - including the endothelium - with implications for lupus nephritis and accelerated atherosclerosis.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/22617827", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 1537, 
            "offsetInEndSection": 1902, 
            "text": "Active NOS, NOX, and MPO within NETs significantly modify HDL, rendering the lipoprotein proatherogenic. Since NET formation is enhanced in SLE, these findings support a novel role for NET-derived lipoprotein oxidation in SLE-associated CVD and identify additional proatherogenic roles of neutrophils and putative protective roles of antimalarials in autoimmunity.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/24838349", 
            "endSection": "abstract"
        }
    ]
}